After resuming pre-market trading, shares of Aldeyra (ALDX) are down $4.00, or 75%, to $1.32.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALDX:
- Aldeyra receives Complete Response Letter from FDA for Reproxalap NDA
- Aldeyra receives complete response letter from FDA for reproxalap NDA
- Aldeyra options imply 29.5% move in share price post-earnings
- Aldeyra options imply 30.8% move in share price post-earnings
- Aldeyra Therapeutics: Buy Rating Affirmed on Promising Reproxalap and Strategic RASP Market Expansion